Published in Medical Devices and Surgical Technology Week, November 21st, 2004
Cerner could invest as much as $25 million in this 10-year initiative. There are as many as 1.3 million people in the United States with Type 1 diabetes.
"Over the next 5 years, Cerner will spend $1 billion on research and development," said Neal Patterson, chief executive officer and chairman of Cerner. "We believe it makes sense to use a percentage of that amount to create a national proof point around the benefits of a PHR and to help improve the health outcomes of kids with diabetes."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.